Herb Profile
Boswellia
Boswellia serrata
Boswellia (Boswellia serrata) carries a Grade A rating — strong evidence.
Use extra caution — GI upset Details
- Evidence
- Strong Evidence
- Typical onset
- Varies by prep
- Safety rating
- Moderate caution
- Best for
- Anti Inflammatory, Inflammatory signaling
- Avoid / review if
- NSAIDs (Caution)
Safety
Safety & Cautions
GI upset
Elevated caution
Caution level: Elevated. One caution category applies — read it before use.
Detailed safety fields
Pregnancy, breastfeeding, and contraindications
- NSAIDs (Caution)
Full safety note
- GI upset
Evidence
Evidence Summary
Evidence lens
Most useful for practical interpretation when safety context also fits.
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation
Research maturity: Established research — Long Term Human Evidence May Be Limited.
Safety boundary: Safety note available — GI upset
This profile cites 3 human studies.
Study design details
Grade A: Strong Evidence
Evaluation of methodological rigor, population reach, and evidence alignment.
- Design Match
- Meta-analysis
- Risk of Bias
- Low
- Consistency
- Consistent
How evidence grades work
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
- Strong
- Multiple RCTs, consistent direction, adequate effect size
- Moderate
- Some RCTs or consistent observational data in humans
- Preliminary / Mixed
- Animal or in-vitro only, or conflicting human data
- Traditional / Theoretical
- Traditional use only; no controlled human trials
Clinical Study Summaries (5)4 human evidence sources · 0 human trials · ~545 participants across 1 human evidence source with reported N · Consistency not yet classifiable
Filter by study class
Showing 5 of 5 studies.
What the evidence actually shows
This table contains 5 structured sources, including 4 human evidence sources; 0 are human trials. Across 1 human evidence source with a reported sample size, the approximate participant total is 545; overlapping publications may include some of the same people.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis Liu X et al. · Br J Sports Med · 2018 Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | — | PubMed → |
Yu G et al. · BMC Complement Med Ther · 2020 Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | n=545 | — | — | — | — | — | PubMed → |
Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | A 2026 network meta-analysis found that modified Boswellia serrata formulations improved WOMAC pain, stiffness, and knee-function outcomes; benefits of combined Curcuma-Boswellia products remained insufficiently established. | PubMed → |
Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | A nine-trial synthesis reported improvements in pain, stiffness, and function with Boswellia preparations, but standardized-extract subgrouping and formulation differences are important. The evidence is osteoarthritis-specific and should not become a general anti-inflammatory claim. | PubMed → |
Frankincense--therapeutic properties Al-Yasiry AR et al. · Postepy Hig Med Dosw (Online) · 2016 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
Dosing & Timing
- Dose guidance
- 100 250 mg AKBA standardized extract
How Boswellia works
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Boswellia Works
Mechanisms & biological pathways (preclinical)
- Inflammatory Signaling Modulation
Active Compounds
Key constituents studied in Boswellia, with full pharmacology and safety profiles.
Compare related active botanicals
Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.
Compare & Sourcing
Compare side-by-side tradeoffs or verify active marker guidelines.
Sourcing options
Boswellia product picks
Recommendation status
Product recommendations are not shown for this profile because the current site safety and monetization policy does not permit them.
Product form & quality guidelines
When sourcing Boswellia, verify the label for:
- Standardized extract: Confirm active content percentages on the supplement facts panel (e.g. standardized to specific marker compounds) rather than simple raw herb weights.
- Third-party testing: Look for independent purity labels (USP, NSF, ConsumerLab, or Eurofins) to ensure the product is free from heavy metals, solvents, and contaminants.
- Form bioavailability: Ensure the form matches evidence-supported configurations (e.g. standardized active extracts like bacosides, withanolides, or curcuminoids) for optimal onset and digestion tolerance.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Founder & Head Researcher · Oak Ridge, TN · Last reviewed August 2026
Editorial Review
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
Was this useful for your research?
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Free safety checklist
Get the Boswellia research notes
Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.